Barclays’s Evogene EVGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-5
| Closed | – | – | 3391 |
|
2021
Q3 | $0 | Sell |
5
-7
| -58% | – | ﹤0.01% | 3993 |
|
2021
Q2 | $0 | Buy |
12
+7
| +140% | – | ﹤0.01% | 4115 |
|
2021
Q1 | $0 | Buy |
+5
| New | – | ﹤0.01% | 3914 |
|
2020
Q2 | – | Sell |
-70
| Closed | -$1K | – | 3827 |
|
2020
Q1 | $1K | Hold |
70
| – | – | ﹤0.01% | 3610 |
|
2019
Q4 | $1K | Hold |
70
| – | – | ﹤0.01% | 3811 |
|
2019
Q3 | $1K | Sell |
70
-29
| -29% | -$414 | ﹤0.01% | 4035 |
|
2019
Q2 | $2K | Hold |
99
| – | – | ﹤0.01% | 4137 |
|
2019
Q1 | $2K | Buy |
+99
| New | +$2K | ﹤0.01% | 4153 |
|
2018
Q4 | – | Sell |
-4,933
| Closed | -$153K | – | 4169 |
|
2018
Q3 | $153K | Hold |
4,933
| – | – | ﹤0.01% | 3197 |
|
2018
Q2 | $141K | Hold |
4,933
| – | – | ﹤0.01% | 2926 |
|
2018
Q1 | $157K | Hold |
4,933
| – | – | ﹤0.01% | 2964 |
|
2017
Q4 | $151K | Hold |
4,933
| – | – | ﹤0.01% | 2809 |
|
2017
Q3 | $219K | Hold |
4,933
| – | – | ﹤0.01% | 2347 |
|
2017
Q2 | $250K | Hold |
4,933
| – | – | ﹤0.01% | 2318 |
|
2017
Q1 | $264K | Hold |
4,933
| – | – | ﹤0.01% | 2338 |
|
2016
Q4 | $252K | Hold |
4,933
| – | – | ﹤0.01% | 2184 |
|
2016
Q3 | $315K | Hold |
4,933
| – | – | ﹤0.01% | 1935 |
|
2016
Q2 | $308K | Hold |
4,933
| – | – | ﹤0.01% | 1959 |
|
2016
Q1 | $296K | Sell |
4,933
-781
| -14% | -$46.9K | ﹤0.01% | 1932 |
|
2015
Q4 | $457K | Buy |
5,714
+246
| +4% | +$19.7K | ﹤0.01% | 1725 |
|
2015
Q3 | $438K | Buy |
5,468
+265
| +5% | +$21.2K | ﹤0.01% | 1783 |
|
2015
Q2 | $417K | Buy |
5,203
+270
| +5% | +$21.6K | ﹤0.01% | 1829 |
|
2015
Q1 | $395K | Hold |
4,933
| – | – | ﹤0.01% | 2031 |
|
2014
Q4 | $444K | Hold |
4,933
| – | – | ﹤0.01% | 2047 |
|
2014
Q3 | $641K | Hold |
4,933
| – | – | ﹤0.01% | 1871 |
|
2014
Q2 | $789K | Sell |
4,933
-143
| -3% | -$22.9K | ﹤0.01% | 1808 |
|
2014
Q1 | $964K | Buy |
5,076
+143
| +3% | +$27.2K | ﹤0.01% | 1680 |
|
2013
Q4 | $937K | Buy |
+4,933
| New | +$937K | ﹤0.01% | 1810 |
|